SHINE Technologies receives EU CMA for Ilumira Lu-177 radioisotope
June 1, 2026
The development coincides with several steps by SHINE Technologies to broaden its position in nuclear medicine.
The development coincides with several steps by SHINE Technologies to broaden its position in nuclear medicine.